Methodology Pricing

Vertex Pharmaceuticals Incorporated

VRTX

HealthcareBiotechnologyNASDAQ

$456.61

Market Cap: $115.82B

Valuation Financials Forecast Compare Historical Price Solvency Dividends Transactions People

Valuation Summary Discounted Cash Flow Trading Multiples PEG Fair Value Earnings Power Value Analyst Estimates Dividend Discount ModelSoon WACC

Similar Stocks to VRTX

Coming soon

Vertex Pharmaceuticals Incorporated (VRTX) Analyst Estimates

SweetValueLab © 2026

Methodology Pricing About

Not financial advice. Data may be delayed.

No price target data available for VRTX.